India Pesticides Limited has informed the Exchange about financial results for the period ended 31-Dec-2025 in Machine Readable Form / Legible copy
IPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
India Pesticides Limited reported its unaudited standalone and consolidated financial results for Q3 and 9M FY26 ended 31 December 2025, along with the re-appointment of Mr. Dheeraj Kumar Jain as CEO for a second 5-year term (23 Jan 2026 to 22 Jan 2031). Standalone revenue from operations grew strongly to Rs. 225.93 Cr in Q3 (up ~31% YoY from Rs. 172.22 Cr) and Rs. 790.96 Cr for 9M FY26 (up ~27% YoY). Standalone profit after tax rose to Rs. 21.11 Cr in Q3 and Rs. 90.55 Cr for 9M FY26 (up ~42% YoY from Rs. 63.90 Cr), with 9M EPS at Rs. 7.86 vs Rs. 5.55. Other income for 9M includes a one-time Rs. 2.29 Cr insurance claim settlement from a long-pending FY 2013-14 litigation. The statutory auditor (Suresh Surana & Associates LLP) issued an unmodified limited review report, though it noted an ongoing Income Tax block-period assessment (FY19 to FY25) post a December 2024 search, for which the company has paid Rs. 0.18 Cr and believes no material impact is likely.
Strong topline growth and healthy bottom-line expansion suggest improved operating performance; the stock may react positively to the earnings beat. The re-appointment of the experienced CEO provides leadership continuity. Investors should watch the pending Income Tax assessment, though management views the impact as not material.